November 15, 2016

Florida pharmacies Lemon Bay Drugs North, Inc. and Brooksville Drugs, Inc. agreed to pay a total of $750,000 to resolve allegations that the pharmacies violated the False Claims Act by causing claims to be submitted to federal health care programs for prescription drugs that were never dispensed.  According to the government, the pharmacies provided Medicare and Medicaid patients generic versions of certain medications, but charged Medicare and Medicaid for the brand name versions of those medications.  The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by a former pharmacy technician who worked at Lemon Bay Drugs.  She will receive a whistleblower award of $142,500 from the proceeds of the government’s recovery.  DOJ (MDFL)

Tagged in: FCA Federal, Pharma Fraud, Whistleblower Case, Whistleblower Rewards,